No profile data available.
RxSight, Inc. (RXST) is a healthcare company in the targeted healthcare equipment industry, based in Aliso Viejo, United States, with about 461 full-time employees.
It reported revenue of $134.48 million for fiscal year 2025, down 3.9% from fiscal year 2024, and net income of -$38.94 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $33.74 million, up 0.3% from a year before. Its market capitalization was $200.06 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery.
RxSight reported $134.48 million in revenue for fiscal year 2025, down 3.9% from $139.93 million in fiscal year 2024. In Q2 2026 revenue was $33.74 million.
$200.06 million as of October 9, 2026.
Listed companies of a similar size in the same industry (targeted healthcare equipment) include Humacyte, Inc. (HUMA), Utah Medical Products, Inc. (UTMD), Electromed, Inc. (ELMD), Deltex Medical Group plc (DTXMF).